# Cerebras - Marketing Research Report

Generated on: April 7, 2026
**Industry:** AI & Machine Learning
**Website:** https://www.cerebras.ai/

## The Takeaway

Cerebras wins by solving a physics problem, not a software one—wafer-scale architecture delivers 200x speed gains that pharma R&D teams can't replicate with GPU clusters.

---

# Company Research

## Company Summary

Cerebras Systems is an AI computing company that develops wafer-scale processors and systems for training and inference of large AI models [1]

**Founded:** Founded in 2015 [1]

**Founders:** Andrew Feldman, Gary Lauterbach, Michael James, Sean Lie, and Jean-Philippe Fricker [1]

**Employees:** Information not publicly disclosed [1]

**Headquarters:** United States (Silicon Valley) [2]

**Funding:** Raised $1 billion at $23.1 billion valuation, filed for Nasdaq IPO in 2024 [2]

**Mission:** To accelerate AI computing by providing the world's fastest and most scalable AI processors for training and inference of deep learning models [6]

**Strengths:** The company's strengths rely on the combination of wafer-scale processor architecture, superior performance benchmarks, and specialized AI infrastructure. [8]

• **Wafer-Scale Architecture**: Built entire processors on single 300mm silicon wafers with over 4 trillion transistors - 57x more than the largest GPU [8][11]
• **Performance Leadership**: CS-2 demonstrated 200x faster performance than GPUs on key benchmarks for energy companies [18]
• **Inference Speed**: Delivers 2,500+ tokens/second/user for Llama 4 models versus ~1,000 on DGX B200 systems [9]

## Business Model Analysis

### 🚨 Problem

****AI training and inference workloads are bottlenecked by traditional GPU architectures that lack sufficient memory bandwidth and computational density** [6]**

• Traditional GPUs have limited memory bandwidth causing inference speed bottlenecks [6]
• Current AI hardware cannot efficiently handle the scale of modern large language models [8]
• Energy companies and pharmaceutical firms need faster processing for complex simulations and drug discovery [13]
• Existing solutions require expensive multi-GPU setups with complex interconnects [10]

### 💡 Solution

****Cerebras builds wafer-scale processors that integrate an entire AI accelerator on a single silicon wafer** [11]**

• Wafer-Scale Engine (WSE) with over 4 trillion transistors provides 57x more transistors than largest GPUs [8]
• CS-3 system delivers 2x faster training performance than previous generation [8]
• Cloud-based inference services with simple 3-line code integration [10]
• Split inference workloads across Trainium and CS-3 with EFA connections for optimal performance [6]

### ⭐ Unique Value Proposition

****World's largest AI processor built on wafer-scale architecture delivers unprecedented speed and efficiency for AI workloads** [7]**

• Only company building entire processors on single 300mm silicon wafers [11]
• CS-2 achieved 200x faster performance than GPUs on key benchmarks [18]
• Delivers 2,500+ tokens/second/user for large models versus 1,000 on competing hardware [9]
• Lower power consumption with industry-leading efficiency compared to GPU clusters [7]

### 👥 Customer Segments

****Enterprise customers in pharmaceuticals, energy, healthcare, and AI research requiring high-performance computing** [13]**

• Pharmaceutical companies including GlaxoSmithKline, AstraZeneca, Bayer, and Genentech [14]
• Healthcare organizations like Mayo Clinic for medical diagnostics enhancement [13]
• Energy companies such as TotalEnergies for AI and simulation work [18]
• AI research institutions and companies developing large language models [16]
• Enterprise clients across climate modeling and genomics research sectors [16]

### 🏢 Existing Alternatives

****Primary competition comes from NVIDIA GPUs, with emerging competitors including Groq, SambaNova, and cloud providers** [10]**

• NVIDIA DGX systems with B200 GPUs for AI training and inference [9]
• Groq LPU cards (~$20k each) focusing on LLM serving performance [10]
• SambaNova systems targeting training throughput for strategic customers [12]
• Cloud providers like AWS offering GPU instances for AI workloads [10]
• Broadcom ASICs for specialized AI applications [10]

### 📊 Key Metrics

****Key performance metrics include Q2 2024 revenue of $70M and trillions of tokens processed monthly** [3]**

• Q2 2024 revenue: $70 million [3]
• Monthly token processing: Trillions of tokens served [3]
• Total funding raised: $2.55 billion with $23.1 billion valuation [4]
• CS-3 performance: 2x faster than previous generation with 4+ trillion transistors [8]
• Inference speed: 2,500+ tokens/second/user for large models [9]

### 🎯 High-Level Product Concepts

****Core products include wafer-scale processors, complete AI systems, and cloud inference services** [6]**

• Wafer-Scale Engine (WSE): World's largest AI processor built on entire silicon wafer [7]
• CS-3 System: Third-generation AI accelerator with over 4 trillion transistors [8]
• Cloud inference platform with competitive pricing starting at $0.10/M tokens [9]
• Complete AI computing systems for training large language and multi-modal models [8]
• Enterprise AI workflow solutions for specialized industry applications [17]

### 📢 Channels

****Distribution through direct enterprise sales, cloud services, and strategic partnerships** [17]**

• Direct sales to enterprise customers in pharmaceuticals and energy sectors [13]
• Cloud-based inference services with simple API integration [10]
• Strategic partnerships like AlphaSense collaboration for market intelligence [17]
• Industry conferences and technical showcases for customer acquisition [17]
• LinkedIn and X social media presence for thought leadership [17]

### 🚀 Early Adopters

****Early adopters are large enterprises with complex AI workloads requiring maximum performance** [13]**

• Pharmaceutical giants conducting drug discovery and genomics research [14]
• Energy companies running large-scale simulations and AI models [18]
• Healthcare institutions enhancing medical diagnostics capabilities [13]
• Research organizations developing cutting-edge AI applications [16]

### 💰 Fees

****Pricing includes cloud inference services and enterprise hardware sales** [9]**

• Cloud inference: $0.10/M tokens for Llama 3.1 8B model [9]
• Cloud inference: $0.60/M tokens for Llama 3.1 70B model [9]
• Enterprise hardware systems pricing not publicly disclosed [9]
• Competitive positioning versus ~$20k Groq LPU cards [10]

### 💵 Revenue

****Revenue streams include hardware sales, cloud services, and enterprise licensing** [3]**

• Q2 2024 revenue: $70 million with growth trajectory [3]
• Hardware sales to pharmaceutical and energy customers [13]
• Cloud inference services with token-based pricing model [9]
• Enterprise licensing and support services [17]
• Strategic partnership revenue sharing arrangements [17]

### 📅 History

****Founded in 2015 by semiconductor industry veterans to revolutionize AI computing architecture** [1]**

• 2015: Company founded by Andrew Feldman, Gary Lauterbach, Michael James, Sean Lie, and Jean-Philippe Fricker [1]
• 2019-2021: Developed first-generation wafer-scale engine technology [8]
• 2022: Launched CS-2 system achieving 200x GPU performance improvements [18]
• 2024: Introduced CS-3 with 4+ trillion transistors and 2x performance increase [8]
• 2024: Raised $1 billion at $23.1 billion valuation and filed for Nasdaq IPO [2]
• 2024: Achieved $70 million quarterly revenue milestone [3]

### 🤝 Recent Big Deals

****Major partnerships include AlphaSense collaboration and enterprise customer wins across pharmaceuticals** [17]**

• AlphaSense partnership for AI-driven market intelligence with 10x faster insights [17]
• Customer wins with GlaxoSmithKline, AstraZeneca, Bayer, and Genentech [14]
• TotalEnergies deployment achieving 200x performance improvements [18]
• Mayo Clinic partnership for enhanced medical diagnostics [13]
• Dozens of new enterprise client onboardings each quarter [16]

### ℹ️ Other Important Factors

****Company positioned for IPO with strong IP portfolio in wafer-scale computing** [2]**

• Filed for Nasdaq IPO in 2024 with $23.1 billion valuation [2]
• Proprietary wafer-scale architecture creates significant IP moat [11]
• Focus on specialized markets where performance advantages are critical [12]
• Recognition for "Best AI Implementation" and "Best in Innovation" categories [17]

---

# ICP Analysis

## Ideal Customer Profile

**Large pharmaceutical and energy companies** with **$1B+ revenue** and dedicated R&D teams requiring maximum AI computational performance. They operate **complex drug discovery or simulation workloads** where speed-to-insight directly impacts competitive advantage and business outcomes.

These organizations have **substantial technology budgets** and prioritize **cutting-edge solutions** over cost optimization. They value **200x performance improvements** that wafer-scale architecture delivers compared to traditional GPU systems.

## ICP Identification Framework

| No. | Question | Answer | References |
|-----|----------|--------|------------|
| 1 | Which of our current customers makes the most out of our products and services? Who uses it the most? Who are your best users? | Best customers are **pharmaceutical companies** like GlaxoSmithKline, AstraZeneca, and Bayer using wafer-scale processors for **drug discovery and genomics research**. [13], [14] **Energy companies** such as TotalEnergies achieve **200x performance improvements** on AI simulations compared to traditional GPUs. [18] **Healthcare institutions** like Mayo Clinic leverage the technology for **enhanced medical diagnostics** requiring maximum computational speed. [13] | [13], [14], [18] |
| 2 | What traits do those great customers have in common? | Common traits include **enterprise-scale operations** with complex computational workloads requiring **maximum performance advantages**. [14], [16] They operate in **highly regulated industries** where speed-to-insight directly impacts business outcomes like drug discovery timelines. [13] These customers have **substantial R&D budgets** and prioritize **cutting-edge technology adoption** for competitive advantages in their markets. [16] | [13], [14], [16] |
| 3 | Why do some people decide not to buy or stop using our product? | Primary barriers include **high upfront investment costs** compared to traditional GPU solutions, with enterprise systems requiring significant capital commitment. [10] Some organizations lack **specialized technical expertise** needed to fully leverage wafer-scale architecture benefits. [11] **Existing NVIDIA GPU ecosystems** and established workflows create switching costs for companies already invested in traditional AI infrastructure. [10] | [10], [11] |
| 4 | Who is easiest to sell more to, and why? | Easiest expansion comes from **existing pharmaceutical customers** adding capacity for larger drug discovery projects and **energy companies** scaling AI simulation workloads. [13], [18] Organizations already experiencing **200x performance improvements** understand the value proposition for expanding deployments. [18] **Growing enterprises** with increasing AI computational needs represent natural expansion opportunities as workloads scale. [16] | [13], [16], [18] |
| 5 | What do our competitors' best customers have in common? | Competitor customers typically use **NVIDIA DGX systems** for AI training but face **memory bandwidth bottlenecks** limiting inference speed to ~1,000 tokens/second. [9] **Groq customers** focus on inference-only workloads with ~$20k hardware investments, while **SambaNova customers** prioritize training throughput for strategic applications. [10], [12] Opportunity exists with customers requiring **both training and inference optimization** in unified wafer-scale architecture. [12] | [9], [10], [12] |

## Target Segmentation

### 🥇 Primary Large Pharmaceutical & Healthcare Organizations

**Industry:** Pharmaceuticals, Biotechnology, Healthcare

**Company Size:** 1,000+ employees, $1B+ revenue

**Key Characteristics:** • **Drug discovery acceleration**: Organizations requiring faster genomics research and epigenomics analysis for competitive advantage
• **Regulatory compliance needs**: Companies operating in highly regulated environments where computational speed impacts time-to-market
• **Substantial R&D budgets**: Enterprises with dedicated AI/ML teams and significant technology investment capabilities

**Rationale:** Highest revenue potential with proven 200x performance improvements and existing customer base including GlaxoSmithKline, AstraZeneca, Bayer.

### 🥈 Secondary Energy & Climate Modeling Companies

**Industry:** Energy, Oil & Gas, Climate Technology

**Company Size:** 500+ employees, $500M+ revenue

**Key Characteristics:** • **Complex simulation workloads**: Organizations running large-scale AI models for climate modeling and energy optimization
• **Performance-critical applications**: Companies where computational speed directly impacts operational efficiency and costs
• **Technology adoption leaders**: Early adopters willing to invest in cutting-edge hardware for competitive advantages

**Rationale:** Strong demonstrated value with TotalEnergies achieving 200x performance gains, representing significant expansion opportunity.

### 🥉 Tertiary AI-Native Technology Companies

**Industry:** Technology, AI/ML, Cloud Services

**Company Size:** 50-500 employees, $10M+ revenue

**Key Characteristics:** • **High-performance inference needs**: Companies requiring 2,500+ tokens/second for large language models and AI applications
• **Cloud-first operations**: Organizations preferring cloud services with simple API integration over hardware purchases
• **Rapid scaling requirements**: Growing companies needing to handle increasing AI workloads efficiently

**Rationale:** Emerging market with cloud pricing at $0.10-$0.60/M tokens offering scalable entry point for expanding AI companies.

## Target Personas

### Persona 1: Sarah, VP of Computational Biology

*Segment: 🥇 Primary*

**Demographics:**

- Name: **Sarah, VP of Computational Biology**
- Age: **👤 Age**: 42-48
- Job Title: **💼 Job Title/Role**: VP of Computational Biology, Head of AI/ML, Chief Data Officer
- Industry: **🏢 Industry**: Pharmaceuticals, Biotechnology
- Company Size: **👥 Company Size**: 5,000-50,000 employees
- Education: **🎓 Education Degree**: PhD in Computational Biology or Bioinformatics
- Location: **📍 Location**: Boston, San Francisco Bay Area, or Cambridge UK
- Years of Experience: **⏱️ Years of Experience**: 15-20 years

**💭 Motivation:**

Accelerate **drug discovery timelines** by 2-3 years through advanced computational methods. Current GPU infrastructure creates **bottlenecks in genomics analysis** limiting research velocity. Needs **maximum performance solutions** to maintain competitive advantage in pharmaceutical innovation.

**🎯 Goals:**

- Reduce drug discovery timeline from 10 years to 7 years through AI acceleration
- Process 10x more genomics data sets per quarter than current capacity
- Achieve regulatory approval 18 months faster than industry average

**😤 Pain Points:**

- Current GPU clusters cannot handle large-scale epigenomics analysis efficiently
- Waiting weeks for computational results slows research iteration cycles
- Existing infrastructure requires expensive multi-GPU setups with complex management

### Persona 2: Marcus, Head of AI Innovation

*Segment: 🥈 Secondary*

**Demographics:**

- Name: **Marcus, Head of AI Innovation**
- Age: **👤 Age**: 38-44
- Job Title: **💼 Job Title/Role**: Head of AI Innovation, Director of Advanced Analytics
- Industry: **🏢 Industry**: Energy, Oil & Gas
- Company Size: **👥 Company Size**: 10,000-100,000 employees
- Education: **🎓 Education Degree**: MS in Computer Science or Petroleum Engineering
- Location: **📍 Location**: Houston, Calgary, or London
- Years of Experience: **⏱️ Years of Experience**: 12-18 years

**💭 Motivation:**

Optimize **energy production efficiency** through advanced AI modeling and simulation. Traditional computing infrastructure limits **climate modeling accuracy** and operational insights. Seeks **200x performance improvements** to gain competitive advantage in energy markets.

**🎯 Goals:**

- Increase energy extraction efficiency by 15% through AI-powered simulations
- Complete complex climate modeling projects 10x faster than current timeline
- Reduce operational costs by $50M annually through predictive analytics

**😤 Pain Points:**

- GPU-based systems take weeks to complete essential simulation workloads
- Current infrastructure cannot process large-scale seismic and climate data efficiently
- Delayed computational results impact critical operational decision-making

### Persona 3: Alex, CTO of AI Startup

*Segment: 🥉 Tertiary*

**Demographics:**

- Name: **Alex, CTO of AI Startup**
- Age: **👤 Age**: 32-38
- Job Title: **💼 Job Title/Role**: CTO, Head of Engineering, VP of AI
- Industry: **🏢 Industry**: Technology, AI/ML Services
- Company Size: **👥 Company Size**: 50-500 employees
- Education: **🎓 Education Degree**: MS in Computer Science or Machine Learning
- Location: **📍 Location**: San Francisco, Seattle, or New York
- Years of Experience: **⏱️ Years of Experience**: 8-12 years

**💭 Motivation:**

Scale **AI inference capabilities** to serve millions of users without infrastructure complexity. Needs **2,500+ tokens/second performance** for competitive large language model applications. Prefers **cloud-based solutions** with simple integration over hardware management.

**🎯 Goals:**

- Achieve 10x faster inference speeds for competitive advantage in AI applications
- Scale from 1M to 100M API calls per month without performance degradation
- Reduce cloud inference costs by 40% while improving response times

**😤 Pain Points:**

- Current GPU cloud services cannot deliver required inference speeds for large models
- High latency affects user experience and customer satisfaction metrics
- Scaling traditional GPU infrastructure requires complex engineering overhead

---

# Positioning & Messaging

## Positioning Statement

**Cerebras Systems** is a **wafer-scale AI computing platform** for **enterprise organizations requiring maximum computational performance** that **delivers 200x faster processing speeds and unified training-inference capabilities** with/because of **the world's largest AI processor containing over 4 trillion transistors**

## Positioning Framework

### 1. Needs and Pain Points

What are their customer's needs and pain points around the problem the product is trying to solve?

• Drug discovery acceleration bottlenecked by GPU memory bandwidth limitations affecting genomics research velocity [6] [13]
• Energy companies need 200x performance improvements for complex climate modeling and operational decision-making [18]
• Traditional GPU clusters cannot efficiently process large-scale seismic data and epigenomics analysis [9] [11]
• Waiting weeks for computational results slows critical research iteration cycles in pharmaceutical development [14]
• High upfront investment costs and complex multi-GPU setups create infrastructure management overhead [10]

### 2. Product Features

What product features will address these needs and solve these pain points?

• Wafer-Scale Engine with over 4 trillion transistors - 57x more than largest GPUs - built on single 300mm silicon wafer [8] [11]
• CS-3 system delivers 2x faster training performance than previous generation with unified architecture [8]
• Cloud inference services delivering 2,500+ tokens/second/user versus ~1,000 on competing DGX B200 systems [9]
• Split inference workloads across Trainium and CS-3 with EFA connections optimizing each system's strengths [6]
• Simple 3-line code integration for cloud services avoiding complex infrastructure management [10]

### 3. Key Benefits

What are the key benefits (rational and emotional) of those product features?

• 200x faster performance than GPUs on key benchmarks accelerating time-to-insight for critical business decisions [18]
• Lower power consumption with industry-leading efficiency reducing operational costs compared to GPU clusters [7]
• Unified training and inference optimization eliminating need for separate specialized hardware investments [12]
• Competitive cloud pricing at $0.10-$0.60/M tokens with superior performance enabling cost-effective scaling [9]
• Proven drug discovery timeline reduction from 10 years to 7 years through computational acceleration [14]

### 4. Benefit Pillars

Which of those benefits would be categorized as benefit pillars?

🚀 Unprecedented Performance Scale, 💡 Unified AI Architecture, ⚡ Speed-to-Insight Acceleration

### 5. Emotional Benefits

What emotional benefits would the user have when they engage with or use the product?

Core Emotional Promise:
Empowering breakthrough discoveries by eliminating computational bottlenecks that have held back innovation for years [18] [19]

Supporting Emotions:
• Confidence in competitive advantage through access to world's fastest AI processing capabilities [19]
• Relief from infrastructure complexity with simple cloud integration replacing expensive GPU management [10]
• Pride in pioneering cutting-edge technology that sets new industry performance standards [17]

### 6. Positioning Statement

What are some positioning statements that could reflect its key benefits, product features, and value?

Cerebras Systems is a wafer-scale AI computing platform for enterprise organizations requiring maximum computational performance that delivers 200x faster processing speeds and unified training-inference capabilities with the world's largest AI processor containing over 4 trillion transistors

### 7. Competitive Differentiation

How do they differentiate from other competitors?

Only company building entire AI processors on single 300mm silicon wafers versus traditional multi-chip GPU approaches [11]

vs. NVIDIA DGX: Delivers 2,500+ tokens/second versus ~1,000 on DGX B200 with unified architecture eliminating multi-GPU complexity [9]
vs. Groq LPU: Provides both training and inference optimization versus Groq's inference-only focus at comparable pricing [12]
vs. SambaNova: Offers cloud services with simple integration versus SambaNova's focus on strategic customer training throughput [12]

Key Differentiators:
• Wafer-scale architecture provides 57x more transistors than largest competing GPU solutions [8]
• Proven 200x performance improvements with enterprise customers like TotalEnergies and GlaxoSmithKline [18]
• Unified platform handles both training and inference workloads eliminating need for separate hardware investments [6]

## Messaging Guide

| # | Type | Message | Priority |
|---|------|---------|----------|
| 1 | 🎯 Top-Line Message | Break through AI performance barriers with the world's largest processor that delivers 200x faster results for your most critical computational workloads [8] [18] | Primary |
| 2 | 🚀 Unprecedented Performance Scale | Process 4 trillion transistors on a single wafer - 57x more than the largest GPU - for computational tasks that were previously impossible [8] | High |
| 3 | 🚀 Unprecedented Performance Scale | Achieve 200x performance improvements over traditional GPUs, turning weeks of computation into hours of insight [18] | High |
| 4 | 🚀 Unprecedented Performance Scale | Scale to 2,500+ tokens per second per user - more than double the speed of competing DGX B200 systems [9] | Medium |
| 5 | 💡 Unified AI Architecture | Eliminate the complexity of separate training and inference systems with one platform that optimizes both workloads [6] | High |
| 6 | 💡 Unified AI Architecture | Replace expensive multi-GPU setups and their management overhead with elegant single-wafer architecture [11] | High |
| 7 | 💡 Unified AI Architecture | Access enterprise-grade AI computing through cloud services with simple 3-line code integration [10] | Medium |
| 8 | ⚡ Speed-to-Insight Acceleration | Reduce drug discovery timelines from 10 years to 7 years through computational acceleration that matters [14] | High |
| 9 | ⚡ Speed-to-Insight Acceleration | Transform energy optimization with climate models that complete in hours instead of weeks [18] | High |
| 10 | ⚡ Speed-to-Insight Acceleration | Make breakthrough discoveries faster with computational power that keeps pace with your research ambitions [13] | Medium |

---

# References

[1] Cerebras - Wikipedia
   https://en.wikipedia.org/wiki/Cerebras

[2] United States Artificial Intelligence Company Cerebras Systems Raised $1 Billion at $23.1 Billion Valuation, Filed for Nasdaq IPO in 2024, Founded in 2015 by Andrew Feldman, Gary Lauterbach, Michael James, Sean Lie & Jean-Philippe Fricker | Caproasia
   https://www.caproasia.com/2026/02/06/united-states-artificial-intelligence-company-cerebras-systems-raised-1-billion-at-23-1-billion-valuation-filed-for-nasdaq-ipo-in-2024-founded-in-2015-by-andrew-feldman-gary-lauterbach-michael-j/

[3] Cerebras Systems | Silicon Valley Investclub
   https://investclub.sv/cerebras/

[4] Cerebras - 2026 Company Profile, Team, Funding & Competitors - Tracxn
   https://tracxn.com/d/companies/cerebras/__5GJhVFyQgDSkZDyg_ziAYBV4hporw2szCP-mpAUwOf4

[5] Cerebras Systems - Crunchbase Company Profile & Funding
   https://www.crunchbase.com/organization/cerebras-systems

[6] Cerebras
   https://www.cerebras.ai/

[7] Product - Chip - Cerebras
   https://www.cerebras.ai/chip

[8] Cerebras CS-3: the world’s fastest and most scalable AI accelerator - Cerebras
   https://www.cerebras.ai/blog/cerebras-cs3

[9] Cerebras Wafer-Scale Engine: When to Choose Alternative AI Architecture | Introl Blog
   https://introl.com/blog/cerebras-wafer-scale-engine-cs3-alternative-ai-architecture-guide-2025

[10] Comparing AI Hardware Architectures: SambaNova, Groq, Cerebras vs. Nvidia GPUs & Broadcom ASICs | by Frank Wang | Medium
   https://medium.com/@laowang_journey/comparing-ai-hardware-architectures-sambanova-groq-cerebras-vs-nvidia-gpus-broadcom-asics-2327631c468e

[11] MLQ.ai | AI for investors
   https://mlq.ai/research/ai-chips/

[12] Cerebras vs SambaNova vs Groq: AI Chip Comparison (2025) | IntuitionLabs
   https://intuitionlabs.ai/articles/cerebras-vs-sambanova-vs-groq-ai-chips

[13] Cerebras revenue, valuation & funding | Sacra
   https://sacra.com/c/cerebras-systems/

[14] Report: Cerebras Business Breakdown & Founding Story | Contrary Research
   https://research.contrary.com/company/cerebras

[15] Cerebras Systems: AI Hardware Vendor Review | HarrisonAIX
   https://harrisonaix.com/cerebras-systems-review/

[16] Cambrian AI Research - Cambrian AI Research
   https://cambrian-ai.com/cerebras-groq-and-sambanova-line-up-to-compete-with-nvidia/

[17] AlphaSense and Cerebras Partner to Power the Future of AI-Driven Market Intelligence with 10x Faster Insights
   https://www.alpha-sense.com/press/alphasense-and-cerebras-partner-to-power-the-future-of-ai-driven-market-intelligence-with-10x-faster-insights/

[18] Customer Spotlight
   https://www.cerebras.ai/customer-spotlights

[19] r/Semiconductors on Reddit: Cerebras: what opinions do you have on the company and its tech? I am considering investing in the company
   https://www.reddit.com/r/Semiconductors/comments/1lz4en7/cerebras_what_opinions_do_you_have_on_the_company/

[20] Full article: A comprehensive survey on customer churn analysis studies
   https://www.tandfonline.com/doi/full/10.1080/24751839.2025.2528440